1ST Source Bank Grows Stock Position in GRAIL, Inc. $GRAL

1ST Source Bank boosted its holdings in GRAIL, Inc. (NASDAQ:GRAL) by 18.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,042 shares of the company’s stock after acquiring an additional 1,555 shares during the period. 1ST Source Bank’s holdings in GRAIL were worth $516,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in GRAL. Farther Finance Advisors LLC increased its position in shares of GRAIL by 768.1% during the 2nd quarter. Farther Finance Advisors LLC now owns 816 shares of the company’s stock worth $42,000 after purchasing an additional 722 shares during the last quarter. NewEdge Advisors LLC lifted its position in GRAIL by 390.3% in the first quarter. NewEdge Advisors LLC now owns 1,760 shares of the company’s stock valued at $45,000 after buying an additional 1,401 shares during the last quarter. Signaturefd LLC boosted its stake in GRAIL by 273.0% during the first quarter. Signaturefd LLC now owns 1,876 shares of the company’s stock worth $48,000 after buying an additional 1,373 shares during the period. Quarry LP increased its position in shares of GRAIL by 1,965.4% during the first quarter. Quarry LP now owns 2,148 shares of the company’s stock valued at $55,000 after acquiring an additional 2,044 shares during the last quarter. Finally, Roble Belko & Company Inc purchased a new stake in shares of GRAIL in the 2nd quarter valued at approximately $68,000.

Insider Buying and Selling

In related news, President Joshua J. Ofman sold 6,114 shares of the company’s stock in a transaction on Thursday, October 16th. The shares were sold at an average price of $82.01, for a total value of $501,409.14. Following the completion of the sale, the president owned 381,818 shares in the company, valued at $31,312,894.18. This represents a 1.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Robert P. Ragusa sold 7,239 shares of the company’s stock in a transaction on Wednesday, October 15th. The shares were sold at an average price of $68.88, for a total transaction of $498,622.32. Following the completion of the sale, the chief executive officer owned 727,388 shares of the company’s stock, valued at approximately $50,102,485.44. This trade represents a 0.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 117,497 shares of company stock valued at $7,515,436. 1.85% of the stock is owned by company insiders.

GRAIL Price Performance

NASDAQ GRAL opened at $79.40 on Monday. GRAIL, Inc. has a 1 year low of $13.58 and a 1 year high of $103.00. The company has a market capitalization of $2.86 billion, a PE ratio of -6.06 and a beta of 4.31. The company has a fifty day moving average of $61.90 and a two-hundred day moving average of $46.74.

GRAIL (NASDAQ:GRAL) last posted its earnings results on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). The firm had revenue of $35.54 million for the quarter, compared to analyst estimates of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. On average, research analysts expect that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on GRAL. Weiss Ratings reissued a “sell (d-)” rating on shares of GRAIL in a research report on Wednesday, October 8th. Canaccord Genuity Group boosted their price objective on GRAIL from $75.00 to $85.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, UBS Group set a $75.00 target price on GRAIL in a research note on Friday, October 3rd. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $60.00.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.